These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 39058886)
1. Evaluation of serum neopterin levels in severe COVID-19 patients: An observational study. Gürcü S; Irmak Kaya Z; Uncu A; Yorulmaz G; Ilgin S Medicine (Baltimore); 2024 Jul; 103(30):e38996. PubMed ID: 39058886 [TBL] [Abstract][Full Text] [Related]
2. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19. Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571 [TBL] [Abstract][Full Text] [Related]
3. Serum neopterin levels in relation to mild and severe COVID-19. Robertson J; Gostner JM; Nilsson S; Andersson LM; Fuchs D; Gisslen M BMC Infect Dis; 2020 Dec; 20(1):942. PubMed ID: 33302893 [TBL] [Abstract][Full Text] [Related]
4. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio. Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory markers and neopterin levels in relation to mild COVID-19. Karabulut A; Şahin M Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8952-8961. PubMed ID: 37782204 [TBL] [Abstract][Full Text] [Related]
6. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity. Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231 [TBL] [Abstract][Full Text] [Related]
7. Retrospective Study of Clinical Features of COVID-19 in Inpatients and Their Association with Disease Severity. Wang H; Xing Y; Yao X; Li Y; Huang J; Tang J; Zhu S; Zhang Y; Xiao J Med Sci Monit; 2020 Dec; 26():e927674. PubMed ID: 33342993 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R Cytokine; 2021 May; 141():155428. PubMed ID: 33550165 [TBL] [Abstract][Full Text] [Related]
9. The prognostic role of neopterin in COVID-19 patients. Ozger HS; Dizbay M; Corbacioglu SK; Aysert P; Demirbas Z; Tunccan OG; Hizel K; Bozdayi G; Caglar K J Med Virol; 2021 Mar; 93(3):1520-1525. PubMed ID: 32860465 [TBL] [Abstract][Full Text] [Related]
10. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19]. Salman E; Çelikbilek N; Aydoğan S; Özdem B; Gökay S; Kırca F; Toyran A; Bilici Salman R; Dinç B Mikrobiyol Bul; 2021 Oct; 55(4):539-552. PubMed ID: 34666654 [TBL] [Abstract][Full Text] [Related]
11. Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019. Ali KM; Ali AM; Tawfeeq HM; Figueredo GP; Rostam HM J Med Virol; 2021 Jul; 93(7):4532-4536. PubMed ID: 33830538 [TBL] [Abstract][Full Text] [Related]
12. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19). Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580 [TBL] [Abstract][Full Text] [Related]
13. Routine laboratory testing to determine if a patient has COVID-19. Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM; Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319 [TBL] [Abstract][Full Text] [Related]
14. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis. Seringec Akkececi N; Yildirim Cetin G; Gogebakan H; Acipayam C Med Sci Monit; 2019 Feb; 25():1401-1409. PubMed ID: 30792377 [TBL] [Abstract][Full Text] [Related]
15. Laboratory parameters related to disease severity and physical performance after reconvalescence of acute COVID-19 infection. Gietl M; Burkert F; Hofer S; Gostner JM; Sonnweber T; Tancevski I; Pizzini A; Sahanic S; Schroll A; Brigo N; Egger A; Bellmann-Weiler R; Löffler-Ragg J; Weiss G; Kurz K Sci Rep; 2024 May; 14(1):10388. PubMed ID: 38710760 [TBL] [Abstract][Full Text] [Related]
16. Could serum albumin value and thrombocyte/lymphocyte ratio be an important prognostic factor in determining the severity of COVID 19? Uyar E; Merdin A; Yamanyar S; Ezgü MC; Artuk C; Taşkın G; Arslan Y; Ceritli S Turk J Med Sci; 2021 Jun; 51(3):939-946. PubMed ID: 33350294 [TBL] [Abstract][Full Text] [Related]
17. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19. Lee A; Nahm CH; Lee JS; Lee MK; Lee KR J Clin Lab Anal; 2021 Nov; 35(11):e24004. PubMed ID: 34608677 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia. Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961 [No Abstract] [Full Text] [Related]
19. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Seyit M; Avci E; Nar R; Senol H; Yilmaz A; Ozen M; Oskay A; Aybek H Am J Emerg Med; 2021 Feb; 40():110-114. PubMed ID: 33309506 [TBL] [Abstract][Full Text] [Related]